Trop-2-targeted tetrameric ranpirnase for therapy of triple-negative breast cance
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA180343
- Recipient
-
Immunomedics, Inc. UEI S4NHH3294XM6
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $171,820
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Morris Plains, NJ 07950, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$28,962 | |
| Original award | $200,782 |
Quick answers
Who received award R43CA180343?
R43CA180343 was awarded to Immunomedics, Inc. by National Institutes of Health (Department of Health and Human Services) on September 3, 2013.
How much is award R43CA180343 worth?
$171,820 has been obligated on R43CA180343.
Which agency awarded R43CA180343?
National Institutes of Health (Department of Health and Human Services) awarded R43CA180343, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award